“I had the pleasure of reporting into Anji Enmyeche for about 5 years at Jubilant Clinsys and would gladly do it all over again. She is an extremely fair and detailed-oriented Director who continuously challenged her staff to improve processes across all roles - CRA, CTA, CTL and her managers. The Jubilant Clinsys Clinical Operations department saw very little turnover during her tenure. She moved the department forward positively while never losing sight of both corporate and departmental strategic objectives and goals.”
Anjanette Enmyeche
Wilmington, North Carolina, United States
790 followers
500+ connections
Wilmington, North Carolina, United States
790 followers
500+ connections
Über uns
Over 20 years of clinical research experience including proposal/contract administration,…
Activity
-
🚨 GLOBAL UPDATE – CLINICAL TRIAL NEWS 🚨 Neurogene Inc. announced that its Phase 1/2 Trial of NGN-101 Gene Therapy for the treatment of CLN5 Batten…
🚨 GLOBAL UPDATE – CLINICAL TRIAL NEWS 🚨 Neurogene Inc. announced that its Phase 1/2 Trial of NGN-101 Gene Therapy for the treatment of CLN5 Batten…
Liked by Anjanette Enmyeche
-
Today, we reported second quarter 2024 financial results and highlighted recent updates. For full details and results, read today’s press release:…
Today, we reported second quarter 2024 financial results and highlighted recent updates. For full details and results, read today’s press release:…
Liked by Anjanette Enmyeche
-
We are excited to announce that the FDA has granted Regenerative Medicine Advanced Therapy #RMAT designation to NGN-401 for #RettSyndrome. RMAT…
We are excited to announce that the FDA has granted Regenerative Medicine Advanced Therapy #RMAT designation to NGN-401 for #RettSyndrome. RMAT…
Liked by Anjanette Enmyeche
Erleben Sie
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Bildung
-
-
-
Activities and Societies: Alpha Kappa Psi Business Fraternity
Recommendations received
-
LinkedIn User
2 people have recommended Anjanette
Join now to viewMore activity by Anjanette
-
Thank you Nasdaq for hosting us for an amazing morning ringing today’s opening bell! Watch the ceremony here: https://bit.ly/4dufaXu #NasdaqBell…
Thank you Nasdaq for hosting us for an amazing morning ringing today’s opening bell! Watch the ceremony here: https://bit.ly/4dufaXu #NasdaqBell…
Liked by Anjanette Enmyeche
-
🥼 Neurogene Inc is on a mission: to improve the lives of patients and families devastated by rare neurological diseases. 🧬 The medicine Neurogene…
🥼 Neurogene Inc is on a mission: to improve the lives of patients and families devastated by rare neurological diseases. 🧬 The medicine Neurogene…
Liked by Anjanette Enmyeche
-
The first day of CTO 2024 is off to a great start! Swing by and see Chris Conner and Ann Conner at booth 29. #CTOEastcoast #ClinicalTrials…
The first day of CTO 2024 is off to a great start! Swing by and see Chris Conner and Ann Conner at booth 29. #CTOEastcoast #ClinicalTrials…
Liked by Anjanette Enmyeche
-
Join me at the Clinical Trials and Clinical Operations track at #DIA2024 to discuss capacity building, policy and geographic reach in Clinical Trials.
Join me at the Clinical Trials and Clinical Operations track at #DIA2024 to discuss capacity building, policy and geographic reach in Clinical Trials.
Liked by Anjanette Enmyeche
-
We are excited to announce that NGN-401 gene therapy for Rett syndrome was one of only three CBER programs selected for inclusion in the FDA’s START…
We are excited to announce that NGN-401 gene therapy for Rett syndrome was one of only three CBER programs selected for inclusion in the FDA’s START…
Liked by Anjanette Enmyeche
-
Today we announced favorable safety data from our ongoing Phase 1/2 trial of NGN-401 in female pediatric patients with Rett syndrome, which will be…
Today we announced favorable safety data from our ongoing Phase 1/2 trial of NGN-401 in female pediatric patients with Rett syndrome, which will be…
Liked by Anjanette Enmyeche
-
Management will participate in the TD Cowen 44th Annual Health Care Conference, Leerink Partners 2024 Global Biopharma Conference, and the Stifel…
Management will participate in the TD Cowen 44th Annual Health Care Conference, Leerink Partners 2024 Global Biopharma Conference, and the Stifel…
Liked by Anjanette Enmyeche
-
We look forward to an excellent conference and connecting with industry leaders and innovators at the Annual JP Morgan Healthcare Conference…
We look forward to an excellent conference and connecting with industry leaders and innovators at the Annual JP Morgan Healthcare Conference…
Liked by Anjanette Enmyeche
-
Following a transformative year, we are pleased to share exciting business updates and anticipated 2024 clinical milestones. Learn…
Following a transformative year, we are pleased to share exciting business updates and anticipated 2024 clinical milestones. Learn…
Liked by Anjanette Enmyeche
-
Wishing all of our wonderful current and future clients a very happy holidays! 2023 has been an incredible year, with so much and so many to be…
Wishing all of our wonderful current and future clients a very happy holidays! 2023 has been an incredible year, with so much and so many to be…
Liked by Anjanette Enmyeche
Other similar profiles
Gemeinsame Artikel erkunden
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More